The Financial Post reports in its Saturday, April 6, edition that until recently, Canada's biggest licensed weed producers have watched valuations skyrocket, driven not by actual sales, but by investor euphoria, hypothetical forecasts of demand and the domino effect of major sector-wide deals. The Post's Vanmala Subramaniam writes that Canopy Growth has dominated coverage of the sector. Analysts covering Canopy have been mostly bullish, but that is changing. Investor are looking for Canopy, and its rivals, to start delivering on their mammoth investments. GMP analyst Martin Landry fears Canopy's near-term growth may disappoint. He suggests that its rivals "could catch up with better inventory availability and significant capacity expansion plans." Canaccord analyst Matt Bottomley is "discouraged" to see Canopy "take a further step back from reaching profitability" due to low inventory and high production costs. Purpose Investments chief investment officer Greg Taylor has lightened up on Canopy shares. He says Canopy is not scaling up as quickly as he thought it would. He adds: "From an economics point of view, they have pretty much sold control to Constellation Brands. Hard to make them our top pick."